New York-based CURE aims to launch its range of CBD-focused functional beverages and dietary supplements in Japan by April, while adapting some of its products to meet regulatory requirements in other Asian markets.
Stronger government regulatory support and the ‘debunking’ of myths surrounding hemp are still at a ‘crucial’ stage in Asia, the success of which is key to unlocking its active nutrition potential.
China’s well thought out regulatory policies for its hemp and CBD industry have been key to establishing a controlled, and growing, open market for downstream consumer products such as food and cosmetics, according to an expert panel.
The UK could be set to emerge as a global leader in the research and development of CBD as a food ingredient after the news that the European Commission has postponed the Novel Food applications of non-synthetic CBD products as it decides whether to class...
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.